Highly efficient inhibition of human immunodeficiency virus type 1 reverse transcriptase by aptamers functionalized gold nanoparticles.

We have developed aptamer (Apt)-conjugated gold nanoparticles (Apt-Au NPs, 13 nm in diameter) as highly effective inhibitors for human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT). Two Apts, RT1t49 (Aptpol) and ODN 93 (AptRH), which recognize the polymerase and RNase H regions of HIV-1 RT, are used to conjugate Au NPs to prepare Aptpol-Au NPs and AptRH-Au NPs, respectively. In addition to DNA sequence, the surface density of the aptamers on Au NPs (nApt-Au NPs; n is the number of aptamer molecules on each Au NP) and the linker length number (Tm; m is the base number of the deoxythymidine linker) between the aptamer and Au NPs play important roles in determining their inhibition activity. A HIV-lentiviral vector-based antiviral assay has been applied to determine the inhibitory effect of aptamers or Apt-Au NPs on the early stages of their replication cycle. The nuclease-stable G-quadruplex structure of 40AptRH-T45-Au NPs shows inhibitory efficiency in the retroviral replication cycle with a decreasing infectivity (40.2%).

[1]  Chad A Mirkin,et al.  Polyvalent DNA nanoparticle conjugates stabilize nucleic acids. , 2020, Nano letters.

[2]  Wei Wang,et al.  Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy. , 2012, Biomaterials.

[3]  W. Tan,et al.  Aptamer-nanoparticle assembly for logic-based detection. , 2012, ACS applied materials & interfaces.

[4]  Tao Chen,et al.  Pattern recognition of cancer cells using aptamer-conjugated magnetic nanoparticles. , 2012, ACS nano.

[5]  B. Ye,et al.  A label-free fluorescent molecular beacon based on DNA-templated silver nanoclusters for detection of adenosine and adenosine deaminase. , 2012, Chemical communications.

[6]  Robert Langer,et al.  Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. , 2012, ACS nano.

[7]  Huan‐Tsung Chang,et al.  Colorimetric detection of platelet-derived growth factors through competitive interactions between proteins and functional gold nanoparticles. , 2011, Biosensors & bioelectronics.

[8]  L. Waters,et al.  Drug combinations for HIV: what’s new? , 2011, Expert review of anti-infective therapy.

[9]  Jian-hui Jiang,et al.  Aptamer-conjugated nanomaterials and their applications. , 2011, Advanced drug delivery reviews.

[10]  Yun-Ling Luo,et al.  Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy. , 2011, ACS nano.

[11]  Huan‐Tsung Chang,et al.  Highly efficient control of thrombin activity by multivalent nanoparticles. , 2011, Chemistry.

[12]  M. Kieny,et al.  Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review. , 2011, Vaccine.

[13]  Michael Famulok,et al.  Aptamer modules as sensors and detectors. , 2011, Accounts of chemical research.

[14]  Xiu‐Ping Yan,et al.  Ultrasensitive, selective and simultaneous detection of cytochrome c and insulin based on immunoassay and aptamer-based bioassay in combination with Au/Ag nanoparticle tagging and ICP-MS detection , 2011 .

[15]  B. Yan,et al.  Cancer-targeting multifunctionalized gold nanoparticles in imaging and therapy. , 2011, Current medicinal chemistry.

[16]  Jun‐Jie Zhu,et al.  Aptamer-based PDMS-gold nanoparticle composite as a platform for visual detection of biomolecules with silver enhancement. , 2011, Biosensors & bioelectronics.

[17]  Tao Chen,et al.  Aptamer-conjugated nanomaterials for bioanalysis and biotechnology applications. , 2011, Nanoscale.

[18]  Yong Wang,et al.  Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging , 2011, Analytical and bioanalytical chemistry.

[19]  A. Mescalchin,et al.  Oligomeric Nucleic Acids as Antivirals , 2011, Molecules.

[20]  E. Wang,et al.  G-Quadruplex-based DNAzyme for colorimetric detection of cocaine: using magnetic nanoparticles as the separation and amplification element. , 2011, The Analyst.

[21]  T. Maekawa,et al.  Aptamer conjugated magnetic nanoparticles as nanosurgeons , 2010, Nanotechnology.

[22]  Sarah W. Read,et al.  Nanotechnology and HIV: potential applications for treatment and prevention. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[23]  L. Cerchia,et al.  Targeting cancer cells with nucleic acid aptamers. , 2010, Trends in biotechnology.

[24]  Y. Jeong,et al.  A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. , 2010, ACS nano.

[25]  B. Liu,et al.  Anionic conjugated polymer with aptamer-functionalized silica nanoparticle for label-free naked-eye detection of lysozyme in protein mixtures. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[26]  Yi Lu,et al.  Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates. , 2010, Advanced drug delivery reviews.

[27]  Sadia Afrin Khan,et al.  Multifunctional oval-shaped gold-nanoparticle-based selective detection of breast cancer cells using simple colorimetric and highly sensitive two-photon scattering assay. , 2010, ACS nano.

[28]  R. Langer,et al.  Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. , 2010, Nanomedicine.

[29]  L. Chen,et al.  Aptamer-based silver nanoparticles used for intracellular protein imaging and single nanoparticle spectral analysis. , 2010, The journal of physical chemistry. B.

[30]  Youcef Mehellou,et al.  Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go? , 2010, Journal of medicinal chemistry.

[31]  Ming Zhou,et al.  Solid-state probe based electrochemical aptasensor for cocaine: a potentially convenient, sensitive, repeatable, and integrated sensing platform for drugs. , 2010, Analytical chemistry.

[32]  A. Heckel,et al.  Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency , 2009, Nucleic acids research.

[33]  W. Tan,et al.  Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells. , 2009, Analytical chemistry.

[34]  P. Giangrande,et al.  Therapeutic applications of DNA and RNA aptamers. , 2009, Oligonucleotides.

[35]  H. Doerr,et al.  Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus , 2009, Medical Microbiology and Immunology.

[36]  S. Sarafianos,et al.  Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. , 2009, Journal of molecular biology.

[37]  S. Sakai,et al.  Target-selective photo-degradation of HIV-1 protease by a fullerene-sugar hybrid. , 2008, Chemical communications.

[38]  R. Shattock,et al.  Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor , 2008, Antimicrobial Agents and Chemotherapy.

[39]  R. Mackman,et al.  Novel Nucleotide Human Immunodeficiency Virus Reverse Transcriptase Inhibitor GS-9148 with a Low Nephrotoxic Potential: Characterization of Renal Transport and Accumulation , 2008, Antimicrobial Agents and Chemotherapy.

[40]  A. Ellington,et al.  Aptamers that recognize drug-resistant HIV-1 reverse transcriptase , 2008, Nucleic acids research.

[41]  J. Aradi,et al.  4‐Thio‐deoxyuridylate‐modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growth on subendothelial matrix , 2008, Journal of thrombosis and haemostasis : JTH.

[42]  R. Draghia‐Akli,et al.  DNA vaccination and gene therapy: optimization and delivery for cancer therapy , 2008, Expert review of vaccines.

[43]  Gengfeng Zheng,et al.  A new approach to amplified telomerase detection with polyvalent oligonucleotide nanoparticle conjugates. , 2008, Journal of the American Chemical Society.

[44]  N. Sugimoto,et al.  Molecular crowding effects on structure and stability of DNA. , 2008, Biochimie.

[45]  Christian Melander,et al.  Inhibition of HIV fusion with multivalent gold nanoparticles. , 2008, Journal of the American Chemical Society.

[46]  J. Margolick,et al.  Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase , 2008, AIDS.

[47]  Kun-Hong Lee,et al.  Bioconjugated gold nanodots and nanoparticles for protein assays based on photoluminescence quenching. , 2008, Analytical chemistry.

[48]  C. Mirkin,et al.  Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. , 2007, Nano letters.

[49]  C. Giancola,et al.  A novel thrombin binding aptamer containing a G-LNA residue. , 2007, Bioorganic & medicinal chemistry.

[50]  D. H. Burke,et al.  Active site binding and sequence requirements for inhibition of HIV-1 reverse transcriptase by the RT1 family of single-stranded DNA aptamers , 2007, Nucleic acids research.

[51]  D. H. Burke,et al.  Single-stranded DNA aptamer RT1t49 inhibits RT polymerase and RNase H functions of HIV type 1, HIV type 2, and SIVCPZ RTs. , 2007, AIDS research and human retroviruses.

[52]  K. Jeang,et al.  Replication of human immunodeficiency virus type 1 from entry to exit , 2006, International journal of hematology.

[53]  Chad A. Mirkin,et al.  Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation , 2006, Science.

[54]  A. Caminade,et al.  Dendritic Catanionic Assemblies: In vitro Anti‐HIV Activity of Phosphorus‐Containing Dendrimers Bearing Galβ1cer Analogues , 2005, Chembiochem : a European journal of chemical biology.

[55]  K. Überla,et al.  Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides , 2005, Retrovirology.

[56]  J. Kilby,et al.  Novel therapies based on mechanisms of HIV-1 cell entry. , 2003, The New England journal of medicine.

[57]  Kemin Wang,et al.  Bioconjugated nanoparticles for DNA protection from cleavage. , 2003, Journal of the American Chemical Society.

[58]  Á. McKnight,et al.  Cell surface receptors, virus entry and tropism of primate lentiviruses. , 2002, The Journal of general virology.

[59]  J. Turkevich,et al.  Coagulation of Colloidal Gold , 2002 .

[60]  S. Ropero,et al.  Synergistic Interaction Between Vinorelbine and Gamma-Linolenic Acid in Breast Cancer Cells , 2002, Breast Cancer Research and Treatment.

[61]  David Baltimore,et al.  Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.

[62]  O. Naderer,et al.  Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. , 2001, Clinical therapeutics.

[63]  J. Toulmé,et al.  DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity. , 2001, Biochemistry.

[64]  C. Mirkin,et al.  A fluorescence-based method for determining the surface coverage and hybridization efficiency of thiol-capped oligonucleotides bound to gold thin films and nanoparticles. , 2000, Analytical chemistry.

[65]  C. Mirkin,et al.  Scanometric DNA array detection with nanoparticle probes. , 2000, Science.

[66]  F. Szoka,et al.  Fluorometric determination of deoxyribonuclease I activity with PicoGreen. , 2000, Analytical biochemistry.

[67]  A. Shepherd,et al.  High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. , 1999, Journal of virological methods.

[68]  J. Ioannidis,et al.  Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team. , 1998, The New England journal of medicine.

[69]  R. Hepler,et al.  One-step fluorescent probe product-enhanced reverse transcriptase assay. , 1998, BioTechniques.

[70]  S. Kaneko,et al.  RNA-dependent RNA Polymerase Activity of the Soluble Recombinant Hepatitis C Virus NS5B Protein Truncated at the C-terminal Region* , 1998, The Journal of Biological Chemistry.

[71]  Chad A. Mirkin,et al.  One-Pot Colorimetric Differentiation of Polynucleotides with Single Base Imperfections Using Gold Nanoparticle Probes , 1998 .

[72]  L. Gold,et al.  High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. , 1995, Biochemistry.

[73]  J. Culp,et al.  Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors. , 1994, The Journal of biological chemistry.

[74]  T Friedmann,et al.  Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[75]  Fred Wudl,et al.  Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification , 1993 .

[76]  Robin A. Weiss,et al.  How does HIV cause AIDS , 1993 .

[77]  J. Lisziewicz,et al.  Nanomedicine applications towards the cure of HIV. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[78]  Soonhag Kim,et al.  Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle. , 2012, Biomaterials.

[79]  K. Metzner,et al.  Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure , 2011 .

[80]  Zhi Zhu,et al.  Aptamer-incorporated hydrogels for visual detection, controlled drug release, and targeted cancer therapy , 2011, Analytical and Bioanalytical Chemistry.

[81]  T. Cihlar,et al.  Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. , 2010, Antiviral research.

[82]  Luis Menéndez-Arias,et al.  Molecular basis of human immunodeficiency virus drug resistance: an update. , 2010, Antiviral research.

[83]  G. Pozmogova,et al.  Conformation and thermostability of oligonucleotide d(GGTTGGTGTGGTTGG) containing thiophosphoryl internucleotide bonds at different positions. , 2010, Biophysical chemistry.

[84]  J. Krebs,et al.  Novel FRET-based assay to detect reverse transcriptase activity using modified dUTP analogues. , 2008, Bioconjugate chemistry.

[85]  S. Hammer,et al.  Antiretroviral Drug Resistance Testing in Adult Hiv-1 Infection: 2008 Recommendations of an International Aids Society–usa Panel , 2022 .